Disease Biology Archives

Advancing MDS Nursing – Course 2: the treatment of patients with MDS

Nurses are indispensable component to the multidisciplinary team that cares for patients with myelodysplastic syndromes (MDS). As advances in the…

Genomic testing and clinical decision making in CLL – Course 1: The importance of testing

As the treatment of chronic lymphocytic leukemia (CLL) becomes increasingly genomics-driven, performing the appropriate genomic tests and utilizing these results…

Overcoming R/R myeloma with T-cell engaging therapies

VJHemOnc is excited to bring you highlights from the 16th International Workshop on Multiple Myeloma (iwMyeloma) 2023 with leading experts…

Approaching a cure for multiple myeloma

VJHemOnc is excited to bring you highlights from the 16th International Workshop on Multiple Myeloma (iwMyeloma) 2023 with leading experts…

Genomic testing and clinical decision making in CLL courses: exploring why and how to test

As therapeutic strategies for chronic lymphocytic leukemia (CLL) increasingly consider the patients’ genomic landscape, implementing and interpreting appropriate tests is…

Advancing MDS Nursing – Course 1: the biology, diagnosis and management of MDS

Nurses are indispensable component to the multidisciplinary team that cares for patients with myelodysplastic syndromes (MDS). As advances in the…

Chemotherapy: the backbone of lymphoma treatment

VJHemOnc is excited to present the latest developments in the role of chemotherapy across lymphomas

The role of MRD in multiple myeloma

VJHemOnc is pleased to bring you a feature exploring the emerging applications of MRD in multiple myeloma.

MRD as a clinical and regulatory endpoint for AML

VJHemOnc is pleased to bring you a feature exploring the latest thinking on the application of MRD in AML trials…

Biological therapy in NHL: treating with CAR-T versus BiTEs

VJHemOnc is pleased to bring you a feature exploring the latest developments in the treatment of NHL, with leading experts…

Highlights from the 2022 Third Annual Texas MPN Workshop (TMW)

VJHemOnc is excited to bring you the latest updates from the 2022 third annual Texas MPN Workshop, which brought together…

Genomic testing and clinical decision making in CLL

Learn about the importance of performing genomic testing in CLL and how this impacts diagnosis, prognosis and treatment decisions.

Highlights from the Texas MPN Workshop 2021

VJHemOnc is excited to bring you the latest updates from The Texas MPN Workshop: Second Annual Workshop and Meeting, which brought…

ERIC 2020 Presentations

VJHemOnc was official Media Partner for the ERIC 2020 Virtual Meeting, New Frontiers in CLL Research, which took place on 1-3…

EHA 2020 Top Picks

VJHemOnc are excited to present late-breaking abstracts and key trial updates announced at this year’s virtual EHA meeting!

Genetic mutation signifies new MDS subtype

Published in Blood, a special report has proposed a new, distinct subtype of myelodysplastic syndromes (MDS) based on the presence…

features: Disease Biology